Student Fellowship--Myasthenia Gravis or Related Neuromuscular Conditions
Myasthenia Gravis Foundation of America
All Regions
03/15/2009
$5,000

Student Fellowship--Myasthenia Gravis or Related Neuromuscular Conditions

These fellowships are awarded annually to current medical students
or graduate students interested in the scientific basis of myasthenia
gravis or related neuromuscular conditions, serving both to further
scientific inquiries into the nature of these disorders and to
encourage more research. The stipend is up to $5,000.

Annual deadline for applications is March 15.

Myasthenia Gravis Foundation of America
1821 University Ave. W., Suite S256
St. Paul, MN 55104

Telephone: (651)917-6256 or (800)541-5454

Fax: (651)917-1835

Doctoral Student, Graduate Student, Medical Student
Request for Applications--Niemann-Pick Type C (NP-C) disease
Ara Parseghian Medical Research Foundation
All Regions
02/13/2009
$250,000

Ara Parseghian Medical Research Foundation

Request for Applications--Niemann-Pick Type C (NP-C) disease

Niemann-Pick Type C (NP-C) disease is a genetic, neurodegenerative disorder which causes progressive deterioration of the nervous system. It usually affects children by interfering with their ability to metabolize cholesterol. Adult onset may also occur. Large amounts of cholesterol accumulate within the liver, spleen, and brain. This metabolic disorder leads to a series of neurological problems that are ultimately fatal...until a treatment is found!

POTENTIAL APPLICANTS PLEASE NOTE: If you have never received funding from the APMRF, please submit electronically a Letter of Intent as outlined below. This procedure will allow our Scientific Advisory Board to read a brief summary of your proposed research without you having to submit the full grant application.

Please have this letter addressed to the APMRF Scientific Advisory Board to the Foundation office by February 13, 2009. Send the Letter of Intent as an ATTACHMENT to Glen Shepherd, Executive Director: gshepherd@parseghian.org

Our SAB will review all Letters of Intent. You will be notified by April 1 whether or not the SAB would like for you to submit the full grant application for consideration of funding. The full grant applications are due no later than April 30, 2009.
The Letter of Intent should not exceed 2 pages of text (12 font single spaced) and must include the following information in this order:

1. Your name, position, title, institution, address, phone and E-mail address
2. Title of proposed research study
3. The objective of the study and hypothesis to be tested
4. The relevance to Niemann-Pick Type C disease (an extensive literature review is not required)
5. Preliminary data (this is encouraged but not essential)
6. A statement of the methods to be used and a brief description of how the results will be evaluated
7. Estimated amount of award you are requesting and whether for a one- or two-year period
8. Current financial support: List each current grant or contract you have that would overlap with the conduct of this research and how this overlap will be accommodated if APMRF funding is awarded. If there are no such grants, state “NONE”

If you have questions or comments on the Letter of Intent, please contact Glen Shepherd at (520) 577-5106 or gshepherd@parseghian.org

Neurologist, Neuroscientist, Scientist
Coins for Alzheimer's Research Trust
The CART Fund, Inc.
All Regions
12/01/2008
$250,000
The CART Fund, Inc.
Coins for Alzheimer's Research Trust

The Rotary clubs in the states of Georgia and the two Carolinas as well as a number of individual clubs throughout the United States, with the assistance from the American Federation of Aging Research, established in 1996 a new funding program called The CART Fund. The fund has already distributed a total amount of approximately $2,300,000 through grants to ten University Research Centers listed below.

The goal of the fund is to encourage exploratory and developmental AD research projects by providing support for the early and conceptual plans of those projects that may not yet be supported by extensive preliminary data but have the potential to substantially advance biomedical research. This proposal should be distinct from those projects designed to increase knowledge in a well established area unless it is intended to extend previous discoveries toward new directions or applications.

The Rotary CART Fund is inviting interested applicants to submit a LETTER-of-INTENT that includes sufficient detail to communicate the importance of your study as well as information on its feasibility.

Applications may encompass a project period of up to two years with a combined budget for direct cost up to $250,000. No indirect costs are allowed. Domestic public and private institutions are eligible, such as universities, colleges, hospitals and laboratories. This is for NEW projects only. Applications will be deemed ineligible from for-profit organizations as well as those already supported by regular or program grants. Up to two $250,000 awards will be made in 2009.

Dr. John Trojanowski will chair a scientific review group that will triage the letters-of-intent and select a maximum of fifteen deemed to have the highest merit. Those selected will be invited to submit a subsequent standard grant application from which the final recommendation will be made by the review group. The final selection will be made by the CART Fund selection committee

Please submit a letter-of-intent as a PDF file by December 1, 2008. The letter should include the following:

Contact information
A statement containing: the hypothesis of the project; the specific aims; a description of the experimental design, methods and model systems; a statement giving future directions this research could lead including a reference to the health relationship of the project [2 pg. limit].
A biographical statement of the principal investigator [2 pg. limit].
Notifications of the finalists (maximum of 15) will be mailed by January 7, 2009. Investigators whose proposals are accepted for further consideration will be sent a full application form which must be completed and returned by February 16, 2009.

Submit e-mail questions and letters-of-intent to Dr. James B. Puryear, Chairman, CART Grants Program: jimpuryear@comcast.net
Neurologist, Physician Researcher, Scientist
Therapeutics Development Initiative 2009
Michael J. Fox Foundation for Parkinson’s Research
All Regions
01/20/2009
$0

Therapeutics Development Initiative 2009
Pre-Proposal Receipt Date: January 20, 2009 – 6:00pm US ET

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announces the launch of its Therapeutics Development Initiative (TDI) for Spring 2009, a funding mechanism to support and stimulate preclinical Parkinson’s disease research at for-profit institutions. This funding program seeks to support preclinical development of Parkinson’s disease therapies which have the potential for fundamentally altering disease course and/or improving treatment of symptoms above and beyond current standards of care. Proposals must focus on key and critical preclinical studies necessary for developing, optimizing and evaluating therapeutic strategies that if successful can move into human testing.
Responsibility for the planning, direction, and execution of the proposed project will be solely that of the principal investigator who must be an employee of a for-profit entity. Academic investigators may have an advisory role in the project, but the operational and strategic ownership of the project must reside within the company.

Investigators may seek up to two years of funding for preclinical development and testing of novel therapeutic approaches for the treatment or prevention of Parkinson’s disease.

Please note that pre-proposals are mandatory and will be used to evaluate your proposal’s fit with the stated aims and review criteria of the RFP. All pre-proposals received in response to this program will be subjected to a triage process and only those pre-proposals deemed to be of suitable scientific merit will be invited to submit a full application.

MJFF employs an expedited, abbreviated granting mechanism to accelerate discoveries and ultimately translate findings to PD patients more quickly.

Conference Call
MJFF will hold a 45 minute long conference call on December 16, 2008 at 12:00 PM U.S. Eastern Time to clarify and explain the Therapeutics Development Initiative 2009 program and to answer applicants' questions. To participate in this call, you must RSVP via email to conferencecalls@michaeljfox.org. Participants will receive a reply with call-in details.

While there are no restrictions as to the specific approaches to be studied under this RFP,
successful applications are most likely to focus on at least one of the following categories:
o Neuroprotective strategies focused on slowing or preventing the process of neuronal
death.
o Neuroregenerative strategies to restore or replace neuronal function.
o Novel drug delivery mechanisms and/or surgical procedures.
o Innovative therapeutic approaches to treat the motor and non-motor symptoms of PD,
including cognitive dysfunction, autonomic dysfunction, sleep disorders, or depression
among others.
o Therapeutic approaches to alleviate complications of PD treatment including dyskinesias,
etc.

If you would like to contact the Foundation, please call toll-free at 1-800-708-7644, or contact us by regular mail at the following address:

The Michael J. Fox Foundation for Parkinson's Research
Church Street Station
P.O. Box 780
New York, NY 10008-0780

Clinical Pharmacist, Neurochemist, Neurologist, Neuroscientist, Scientist
Linus Pauling Institute Prize for Health Research
Linus Pauling Institute at Oregon State University
All Regions
11/01/2008
$50,000
Linus Pauling Institute Prize for Health Research

The Prize is sponsored by the Linus Pauling Institute at Oregon State University. The LPI functions from the basic premise that an optimum diet and a healthy lifestyle are the key to optimum health. LPI's mission is to determine the function and role of vitamins, essential minerals, and phytochemicals in promoting optimum health and preventing and treating disease; and to determine the role of oxidative/nitrative stress and antioxidants in human health and disease. Major areas of research in the Institute encompass cardiovascular diseases, cancer, aging, and neurodegenerative diseases. The goal of LPI's outreach and education program is to help people everywhere achieve a healthy and productive life, full of vitality, with minimal suffering, and free of cancer and other debilitating diseases. For more information, please visit the Institute's website.

Nature: The Prize consists of $50,000 and a medal, and is awarded biennially. The recipient of the inaugural 2001 Prize was Bruce N. Ames from the University of California, Berkeley, and Children's Hospital Oakland Research Institute. The 2003 Prize went to Harvard University's Walter C. Willett, and the 2005 Prize to Paul Talalay from the Johns Hopkins University School of Medicine. Our 2007 prize winner was Mark Levine from the National Institutes of Health.

Purpose: The Prize recognizes innovation and excellence in research relating to the roles of vitamins, essential minerals, and phytochemicals in promoting optimum health and preventing or treating disease; and the roles of oxidative/nitrative stress and antioxidants in human health and disease. The goal is to stimulate innovative research that enhances our knowledge of the role of diet and lifestyle in the primary and secondary prevention of disease; and the role of oxidative/nitrative stress in disease pathology. The Prize also recognizes successful efforts to disseminate and implement knowledge on diet, lifestyle, and health to enhance public health and reduce suffering from disease.

Procedure: The nominator should submit a nomination letter, two supporting letters solicited from his/her colleagues, and the candidate's up-to-date curriculum vita. The candidate's research accomplishments in light of the purpose of the Prize should be amply described in the letters. The awardee must be present to accept the Prize and deliver a talk at LPI's "Diet and Optimum Health" conference. The next conference will be May 13-16, 2009.

Nomination packages should be sent to:

Barbara McVicar
Linus Pauling Institute
Oregon State University
571 Weniger Hall
Corvallis, OR 97331-6512

Complete nomination materials must be received by November 1, 2008.
Chemist, Dietician, Neurochemist, Neurologist, Neuroscientist, Nutritionist, Oncologist, Physician Researcher, Public Health Expert, Public Health Worker, Scientist
Prize4Life Biomarker Prize - Second Track--Amyotrophic Lateral Sclerosis
Prize4Life
All Regions
11/06/2008
$1,000,000
Prize4Life announced its 2-year $1 million ALS/MND Biomarker Challenge on November 6, 2006.

The Prize4Life Biomarker Prize is divided into two tracks - theoretical findings and real outcomes.

The first track was a call for scientists and researchers from all backgrounds to submit theoretical papers on how they would develop a biomarker for ALS. In May 2007, Prize4Life awarded $15,000 for each of the five best ideas submitted . This track is now closed for submissions.

The second track, currently running, involves identifying an actual ALS biomarker. Anyone can submit a solution to the second track at any time, regardless of whether they participated in the first track.

A prize of up to $1,000,000 will be awarded in track two for the first validated ALS biomarker submitted that meets the desired requirements. Those submitting a solution must provide statistically significant results as proof of the validity of the solution. This challenge will end in November 2008 if a winning solution is not received so send in your solution now!!

A biomarker is a distinctive biological or biologically derived indicator that can mark the presence and/or progression of a disease. A biomarker can take the form of a chemical marker, a mechanical device that measures relevant physiological changes, or combination of the two. Currently, there are no known biomarkers for ALS for either diagnosing or measuring the progression of the disease.

Interested scientists and researchers should REGISTER with Prize4Life.

INNOCENTIVE 4470259
ALS Biomarker
POSTED: NOV 06, 2006
DEADLINE: NOV 06, 2008
$1,000,000 USD
Biochemist, Cell Biologist, Molecular Biologist , Neurologist, Neuroscientist, Physician Researcher
John Dystel Fellowship in Multiple Sclerosis
National Multiple Sclerosis Society
All Regions
02/09/2009
$44,000
John Dystel Fellowship in Multiple Sclerosis

This program, sponsored by the National MS Society and supported by the John Dystel Fellowship Fund, is designed for registered nurses interested in receiving advanced training in MS nursing care. The fellow will practice in a specialized MS clinical setting under the tutelage of an MS nurse expert. Training consists of supervised patient care, exposure to multidisciplinary treatment, and other instructional activities. The program offers candidates two options: a three-month fellowship or a six-month fellowship.

The preferred candidate will hold a bachelor's degree. It is the responsibility of the applicant to arrange the proposed training with an appropriate mentor and institution, prior to formal application. The award for the three-month option is $22,500; the award for the six-month option is $44,000. The award includes the fellow's salary, benefits, and participation in education activities; a $4,000 honorarium for the mentor; and indirect costs (not to exceed 10% of the award).

Completed applications, including all required supporting documents, must be received at the Society by February 9, 2009.
Notification of award will take place by April 20, 2009.
The fellowship will begin June 1, 2009. (Alternate start dates will be considered)
Neuroscience Nurse, Nurse
Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases
American Academy of Neurology
All Regions
11/03/2008
$100,000
Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases
Sponsored by the American Academy of Neurology and the AAN Foundation and funded through the philanthropy of the Potamkin Foundation.

This award recognizes major contributions to the understanding of the causes, prevention, treatment, and cure for Pick's, Alzheimer's, and related diseases.

Presentation
Recipient is expected to present a 20-minute lecture during an aging and dementia scientific session at the 61st AAN Annual Meeting.

Recipient will receive:

Medallion and $100,000 prize
Complimentary registration for 61st Annual Meeting
Recognition at 2009 Awards Luncheon at 61st Annual Meeting
Eligibility
Must be in any of the following biological disciplines: neurology, neuropathology, biochemistry, molecular biology, molecular genetics, chemistry, pharmacology, immunology, physiology, or cell biology

Application Procedure

Applicants should submit one complete set of the following materials:

Completed application form
Current curriculum vitae
Letter citing scientific accomplishments in detail
Two recommendation letters
Up to six selected reprints

Deadline

The deadline to apply for 2009 AAN Scientific Awards is November 3, 2008. Applications will be available in August 2008.

For more information, please contact Erin Jackson at ejackson@aan.com or (651) 695-2704.
Biochemist, Cell Biologist, Chemist, Clinical Pharmacist, Neurologist, Neuroscientist, Physician Researcher, Physiologist, Scientist
Movement Disorders Research Award
American Academy of Neurology
All Regions
11/03/2008
$1,500
Movement Disorders Research Award
Sponsored by the American Academy of Neurology, the Parkinson's Disease Foundation, and the AAN Movement Disorders Section and endowed by the Parkinson's Disease Foundation.

This award recognizes an individual for outstanding work in the field of Parkinson's disease or other movement disorders for either a single outstanding contribution or for lifetime achievement.

Presentation
Recipient is expected to present a 20-minute lecture during a movement disorders scientific session at the 61st AAN Annual Meeting.

Recipient will receive:

Certificate of recognition and $1,500 prize
Complimentary registration for 61st Annual Meeting
Recognition at 2009 Awards Luncheon at 61st Annual Meeting
Eligibility
Must be actively engaged in movement disorders research

Application Procedure
Applicants should submit one complete set of the following materials:

Completed application form Note: Under general description, describe: How applicant’s scientific contributions have created a better understanding of Parkinson’s disease or other movement disorders .
Current curriculum vitae

Deadline

The deadline to apply for 2009 AAN Scientific Awards is November 3, 2008. Applications will be available in August 2008.

For more information, please contact Erin Jackson at ejackson@aan.com or (651) 695-2704.
Distinguished Investigator, Distinguished Scholar, Distinguished Scientist, Established Investigator, Neurologist, Neuroscientist, Physician Researcher, Senior Investigator, Senior Researcher
Jon Stolk Award in Movement Disorders for Young Investigators
American Academy of Neurology
All Regions
11/03/2008
$1,000
Jon Stolk Award in Movement Disorders for Young Investigators
Sponsored by the American Academy of Neurology and endowed by Kyowa Pharmaceutical, Inc., Lineberry Research, Quintiles, Dr. Dennis Gillings, and VelaPharma.

This award recognizes young investigators who have made significant contributions to movement disorders research. The award is named for Dr. Jon Stolk, a driving force in the drug development field for Parkinson's Disease.

Presentation
Recipient is expected to present a 10-minute lecture during a movement disorders scientific session at the 61st AAN Annual Meeting.

Recipient will receive:

Certificate of recognition and $1,000 prize
Complimentary registration for 61st Annual Meeting
Recognition at 2009 Awards Luncheon at 61st Annual Meeting
Eligibility
Must be within 5 years of completing neurology residency

Application Procedure
Applicants should submit one complete set of the following materials:

Completed application form
Letter of recommendation
Maximum 500-word abstract on movement disorders research in which applicant played an important role (abstract will be ineligible for submission to the 2009 Scientific Program)

Deadline

The deadline to apply for 2009 AAN Scientific Awards is November 3, 2008. Applications will be available in August 2008.

For more information, please contact Kyle Krause at kkrause@aan.com or (651) 695-2733.
Junior Researcher, Junior Scientist, Neurologist, Neuroscientist, Physician Researcher, Young Investigator, Young Scientist

23next